查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1883904

全球肠道疾病检测市场

Enteric Disease Testing
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 158 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年，全球肠道传染病检查市场规模将达31亿美元。

2024年全球肠道传染病检查市场规模估计为23亿美元，预计到2030年将达到31亿美元，在分析期间（2024-2030年）内复合年增长率（CAGR）为4.9%。本报告分析的细分市场之一－细菌性肠道传染病检查，预计复合年增长率为4.8%，到分析期末将达到18亿美元。寄生虫性肠道传染病检查细分市场预计在分析期间内复合年增长率为4.1%。

美国市场规模估计为6.075亿美元，而中国市场预计将以7.4%的复合年增长率成长。

预计到2024年，美国肠道传染病检查市场规模将达到6.075亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到6.765亿美元，在2024年至2030年的分析期内，复合年增长率（CAGR）将达到7.4%。其他值得关注的区域市场分析包括日本和加拿大，预计在分析期间内，这两个国家的复合年增长率将分别达到2.4%和4.5%。在欧洲，德国预计将以约2.7%的复合年增长率成长。

全球肠道传染病检查市场－主要趋势与驱动因素概述

肠道传染病检查如何改变公共卫生和疾病控制？

肠道传染病检查透过提供快速、准确和全面的诊断，彻底改变了公共卫生和疾病控制，有效诊断了影响胃肠道的感染疾病。由细菌、病毒和寄生虫引起的肠道感染疾病是全球重要的健康问题，尤其是在清洁用水和卫生条件有限的地区。这些疾病会导致严重的脱水、营养不良，甚至死亡，尤其对儿童和老年人等弱势族群危害更大。快速且准确地诊断肠道感染疾病对于有效治疗、预防感染传播和控制疫情至关重要。现代肠道传染病检查利用先进的诊断技术，包括分子检测、免疫检测和次世代定序，能够以高灵敏度和特异性检测多种病原体。透过帮助医护人员快速确定胃肠道症状的确切原因，肠道传染病检查能够改善患者预后，减少感染传播，并支持旨在控制和预防全球肠道感染疾病的公共卫生工作。

哪些创新将增强肠道传染病检查的功能？

分子诊断、就地检验和多重检测平台技术的进步显着提升了肠道传染病检查能力。其中一个最重要的进展是聚合酵素链锁反应(PCR) 和其他核酸扩增技术的应用，这些技术能够快速、高精度地检测病原体的遗传物质。与传统培养方法需要数天时间相比，这些分子诊断方法可在数小时内识别粪便检体中的特定细菌、病毒和寄生虫。分子诊断的快速性和准确性对于控制集体爆发和迅速为患者提供适当治疗尤为重要，从而降低併发症和感染传播的风险。

即时检测（POC​​T）是另一个改变肠道感染疾病诊断的重要创新。 POCT 设备专为在医院床边或偏远地区使用而设计，无需专业实验室设备即可提供即时结果。这些携带式、易于操作的设备在缺乏传统检测基础设施的资源匮乏地区尤其重要。 POCT 能够快速诊断和治疗现场肠道感染疾病，缩短治疗时间，并提高治疗成功率。这项创新在疫情爆发情况下也至关重要，因为快速识别致病病原体可以阻止疾病传播。

多重检测平台是肠道传染病检查领域的另一个重大进展。这些系统能够同时检测单一检体中的多种病原体，从而对胃肠道症状的潜在病因进行全面分析。当症状可能由多种病原体引起时，例如食源性疾病集体爆发或免疫力缺乏患者，多重检测尤其有效。透过提供广泛的诊断工具，多重检测减少了多次单独检测的需求，从而能够在节省时间和资源的同时，对患者的病情进行彻底的调查。

这些创新使得肠道传染病检查速度更快、更准确、更便捷，这对于有效控制疾病和保护公共卫生至关重要。

肠道传染病检查对公共卫生和病人预后有何影响？

肠道传染病检查对公共卫生和患者预后具有重要意义，它能够及时诊断、治疗和预防影响消化器官系统的感染疾病。对于每位患者而言，准确快速的检测对于识别致病病原体和指导制定合适的治疗策略至关重要。若未能做出正确诊断，患者可能接受无效或不恰当的治疗，导致病程延长、併发症风险增加、医疗成本上升。肠道传染病检查能够实现标靶治疗，从而缩短病程、减轻病情，并最大限度地降低脱水等併发症的风险，尤其对儿童和老年人等弱势群体意义重大。

从公共卫生角度来看，肠道传染病检查对于控制感染疾病的传播至关重要。在社区集体爆发期间快速识别病原体，有助于公共卫生部门有效实施防控措施，例如隔离感染者、发布公共警告以及追踪污染源。对于食源性疾病，快速检测可以识别受污染的食物，从而预防更多病例的发生，并保护公众健康。此外，肠道传染病检查数据还有助于进行监测工作，例如追踪疾病发生率趋势、监测新出现的病原体以及评估公共卫生措施的有效性。

肠道传染病检查在全球卫生领域中发挥着至关重要的作用，尤其是在胃肠道感染疾病负担沉重的地区。在清洁用水和卫生设施匮乏的地区，肠道感染疾病是导致发病率和死亡率的主要原因。透过提供早期发现和治疗所需的工具，肠道传染病检查有助于减轻这些疾病的负担，并支持更广泛的改善弱势群体健康的努力。此外，在难民营等人道环境中，快速且准确的检测方法至关重要，因为肠道感染疾病疫情可能迅速蔓延并造成毁灭性后果。

整体而言，肠道传染病检查对公共卫生的影响是深远的，它能改善患者的治疗效果，加强疾病控制工作，并有助于预防未来的疫情爆发。

哪些趋势正在推动肠道传染病检查市场的成长？

推动肠道传染病检查市场成长的关键趋势包括食源性疾病发病率的上升、诊断技术的进步、对快速检测解决方案日益增长的需求，以及旨在对抗感染疾病的全球公共卫生倡议。食源性疾病的日益增多是肠道传染病检查需求的主要驱动因素。食品供应链的全球化程度不断加深，导致受污染食品引发大规模疫情的风险增加，因此人们更加关注食品安全，也更加需要可靠的检测方法来快速识别和控制此类疫情。

诊断技术的进步，尤其是分子诊断技术的进步，也推动了肠道传染病检查市场的成长。更快、更准确、更经济的诊断工具的开发，扩大了肠道传染病检查的覆盖范围和可及性。诸如基于PCR的检测、次世代定序和多重检测平台等创新技术，即使在资源匮乏的环境下，也能以高灵敏度和特异性同时检测多种病原体。这些进步不仅有助于改善患者照护，还能为监测和疫情应对提供所需数据，从而支持更广泛的公共卫生工作。

对快速检测解决方案日益增长的需求也是推动市场成长的关键趋势。临床和公共卫生领域对能够快速提供检测结果的诊断测试的需求日益增长，以便儘早进行治疗和介入。在疫情爆发和自然灾害等紧急情况下，这种需求尤其明显，因为快速诊断对于预防感染疾病传播和挽救生命至关重要。能够现场快速准确检测的就地检验设备的开发和应用正在满足这一需求，并促进其在各种环境中的应用。

旨在减轻肠道感染负担的全球公共卫生倡议，尤其是在中低收入国家，也推动了肠道传染病检查市场的成长。世界卫生组织（WHO）和美国疾病管制与预防中心（CDC）等机构正在投资旨在改善诊断可及性、加强疾病监测系统以及提高快速应对疫情能力的各项计画。这些努力正在推动对能够支持这些目标的先进肠道传染病检查解决方案的需求。

此外，对抗菌素抗药性（AMR）的关注也影响肠道传染病检查市场。随着人们对抗生素滥用和抗药性病原体增加的担忧日益加剧，准确诊断以确保适当治疗变得愈发重要。能够快速识别致病病原体及其抗药性光谱的肠道传染病检查在对抗抗菌素抗药性方面正变得至关重要。

这些趋势凸显了肠道传染病检查在改善公共卫生、加强疾病控制以及应对感染疾病挑战方面的重要作用。随着市场的不断发展，检测技术的创新和全球卫生倡议有望推动进一步的成长和发展，确保肠道传染病检查继续成为全球医疗保健的重要组成部分。

部分：

检测方法（常规检测、分子诊断检测、其他检测方法）、疾病类型（细菌性肠道感染疾病、寄生虫性肠道感染疾病、病毒性肠道感染疾病）

受访公司范例

  • Apollo Diagnostics
  • bioMerieux Sweden AB
  • Centre for Infectious Disease Research in Zambia（CIDRZ）
  • EntroGen, Inc.
  • Genovate Laboratories Inc.
  • Quest Diagnostics, Inc.
  • TECHLAB, Inc.

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，改变您分析市场和竞争情报的方式。

Market Glass, Inc. 并没有查询LLM 或产业专用的SLM 的典型方法，而是建立了一个由世界各地领域专家精心策划的内容库，其中包括影片文字稿、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在最新发布的报告中，Market Glass, Inc. 将关税对地理市场的影响纳入考量，并根据公司总部所在地、製造地以及进出口（成品和OEM产品）情况，预测企业竞争地位的变化。这种复杂多变的市场现实会从多个方面影响竞争对手，包括增加销货成本、降低盈利和重组供应链，同时也会影响微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 亚太其他地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP11810

Global Enteric Disease Testing Market to Reach US$3.1 Billion by 2030

The global market for Enteric Disease Testing estimated at US$2.3 Billion in the year 2024, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Bacterial Enteric Disease Testing, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Parasitic Enteric Disease Testing segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$607.5 Million While China is Forecast to Grow at 7.4% CAGR

The Enteric Disease Testing market in the U.S. is estimated at US$607.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$676.5 Million by the year 2030 trailing a CAGR of 7.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Enteric Disease Testing Market - Key Trends and Drivers Summarized

How Is Enteric Disease Testing Revolutionizing Public Health and Disease Management?

Enteric disease testing is revolutionizing public health and disease management by providing rapid, accurate, and comprehensive tools for diagnosing infections that affect the gastrointestinal tract. Enteric diseases, caused by bacteria, viruses, or parasites, are a significant global health concern, particularly in areas with limited access to clean water and sanitation. These diseases can lead to severe dehydration, malnutrition, and, in some cases, death, especially among vulnerable populations such as children and the elderly. The ability to quickly and accurately diagnose enteric infections is critical for effective treatment, containment, and prevention of outbreaks. Modern enteric disease testing leverages advanced diagnostic technologies, including molecular assays, immunoassays, and next-generation sequencing, to detect a wide range of pathogens with high sensitivity and specificity. By enabling healthcare providers to identify the exact cause of gastrointestinal symptoms promptly, enteric disease testing is improving patient outcomes, reducing the spread of infections, and supporting public health initiatives aimed at controlling and preventing enteric diseases worldwide.

What Innovations Are Enhancing the Functionality of Enteric Disease Testing?

Innovations in enteric disease testing are enhancing its functionality through advancements in molecular diagnostics, point-of-care testing, and multiplex testing platforms. One of the most significant developments is the use of polymerase chain reaction (PCR) and other nucleic acid amplification techniques, which allow for the rapid detection of genetic material from pathogens with high accuracy. These molecular diagnostic methods can identify specific bacteria, viruses, and parasites in stool samples within hours, compared to traditional culture methods that may take days. The speed and precision of molecular diagnostics are particularly valuable in managing outbreaks and ensuring that patients receive the appropriate treatment quickly, thereby reducing the risk of complications and transmission.

Point-of-care testing (POCT) is another key innovation that is transforming enteric disease diagnostics. POCT devices are designed for use at the bedside or in remote settings, providing immediate results without the need for specialized laboratory equipment. These portable, easy-to-use devices are particularly beneficial in resource-limited areas where access to traditional laboratory infrastructure may be lacking. POCT allows for the rapid diagnosis and treatment of enteric diseases in the field, reducing the time to care and improving the chances of a successful outcome. This innovation is also critical in outbreak situations, where timely identification of the causative pathogen can prevent the spread of disease.

Multiplex testing platforms represent another major advancement in enteric disease testing. These systems can simultaneously detect multiple pathogens from a single sample, providing a comprehensive analysis of potential causes of gastrointestinal symptoms. Multiplex tests are particularly useful in cases where symptoms could be caused by a variety of pathogens, such as in foodborne illness outbreaks or in immunocompromised patients. By providing a broad-spectrum diagnostic tool, multiplex testing reduces the need for multiple individual tests, saving time and resources while ensuring a thorough investigation of the patient’s condition.

These innovations are making enteric disease testing more rapid, accurate, and accessible, which is crucial for effective disease management and the protection of public health.

How Does Enteric Disease Testing Impact Public Health and Patient Outcomes?

Enteric disease testing has a profound impact on public health and patient outcomes by enabling the timely diagnosis, treatment, and prevention of infections that affect the gastrointestinal system. For individual patients, accurate and rapid testing is critical for identifying the specific pathogen responsible for their illness, which guides appropriate treatment. Without proper diagnosis, patients may receive ineffective or inappropriate treatments, leading to prolonged illness, increased risk of complications, and higher healthcare costs. Enteric disease testing allows for targeted therapy, reducing the duration and severity of the illness and minimizing the potential for complications such as dehydration, especially in vulnerable populations like children and the elderly.

From a public health perspective, enteric disease testing is essential for controlling the spread of infectious diseases. Rapid identification of pathogens in community outbreaks allows public health authorities to implement containment measures more effectively, such as isolating infected individuals, issuing public warnings, and tracing the source of contamination. In the case of foodborne illnesses, prompt testing can lead to the identification of contaminated food products, preventing further cases and protecting public health. Moreover, the data generated from enteric disease testing contribute to surveillance efforts, helping to track trends in disease incidence, monitor emerging pathogens, and evaluate the effectiveness of public health interventions.

Enteric disease testing also plays a vital role in global health, particularly in regions with high burdens of gastrointestinal infections. In areas where access to clean water and sanitation is limited, enteric diseases are a leading cause of morbidity and mortality. By providing the tools needed for early detection and treatment, enteric disease testing helps to reduce the burden of these diseases and supports broader efforts to improve health outcomes in vulnerable populations. Additionally, the availability of rapid and accurate testing is crucial in humanitarian settings, such as refugee camps, where outbreaks of enteric diseases can spread quickly and have devastating consequences.

Overall, the impact of enteric disease testing on public health is far-reaching, improving patient outcomes, enhancing disease control efforts, and contributing to the prevention of future outbreaks.

What Trends Are Driving Growth in the Enteric Disease Testing Market?

Several trends are driving growth in the enteric disease testing market, including the increasing incidence of foodborne illnesses, advancements in diagnostic technology, the rising demand for rapid testing solutions, and global public health initiatives aimed at controlling infectious diseases. The growing incidence of foodborne illnesses is a significant factor fueling the demand for enteric disease testing. As globalization of the food supply chain increases, the risk of widespread outbreaks caused by contaminated food products has risen, prompting greater emphasis on food safety and the need for reliable testing methods to quickly identify and contain such outbreaks.

Advancements in diagnostic technology, particularly in molecular diagnostics, are also contributing to the growth of the enteric disease testing market. The development of faster, more accurate, and cost-effective diagnostic tools has expanded the availability and accessibility of enteric disease testing. Innovations such as PCR-based assays, next-generation sequencing, and multiplex platforms have made it possible to detect multiple pathogens simultaneously with high sensitivity and specificity, even in low-resource settings. These advancements are not only improving patient care but also supporting broader public health efforts by providing essential data for surveillance and outbreak response.

The rising demand for rapid testing solutions is another key trend driving market growth. In both clinical and public health settings, there is a growing need for diagnostic tests that can deliver results quickly, allowing for prompt treatment and intervention. This demand is particularly acute in emergency situations, such as outbreaks or natural disasters, where timely diagnosis is critical to preventing the spread of disease and saving lives. The development and deployment of point-of-care testing devices that provide rapid, accurate results in the field are meeting this need and driving adoption in diverse settings.

Global public health initiatives aimed at reducing the burden of enteric diseases, particularly in low- and middle-income countries, are also driving growth in the enteric disease testing market. Organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) are investing in programs to improve access to diagnostics, strengthen disease surveillance systems, and enhance the capacity for rapid response to outbreaks. These efforts are increasing the demand for advanced enteric disease testing solutions that can support these goals.

Additionally, the focus on antimicrobial resistance (AMR) is influencing the enteric disease testing market. With the growing concern over the misuse of antibiotics and the rise of resistant pathogens, there is an increasing emphasis on accurate diagnosis to ensure appropriate treatment. Enteric disease testing that can rapidly identify the causative pathogen and its resistance profile is becoming essential in the fight against AMR.

These trends highlight the critical role of enteric disease testing in improving public health, enhancing disease management, and responding to the challenges posed by infectious diseases. As the market continues to evolve, innovations in testing technology and global health initiatives will likely drive further growth and development, ensuring that enteric disease testing remains a vital component of healthcare worldwide.

SCOPE OF STUDY:

The report analyzes the Enteric Disease Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Testing Method (Conventional Testing, Molecular Diagnostic Testing, Other Testing Methods); Disease Indication (Bacterial Enteric Disease, Parasitic Enteric Disease, Viral Enteric Disease)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 12 Featured) -

  • Apollo Diagnostics
  • bioMerieux Sweden AB
  • Centre for Infectious Disease Research in Zambia (CIDRZ)
  • EntroGen, Inc.
  • Genovate Laboratories Inc.
  • Quest Diagnostics, Inc.
  • TECHLAB, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Enteric Disease Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Global Prevalence of Enteric Diseases Spurs Demand for Rapid Diagnostic Tests
    • Growing Travel and Migration Contributing to Spread of Enteric Pathogens
    • Integration of Point-of-Care Testing Devices in Remote and Resource-Limited Settings
    • Rising Healthcare Infrastructure Investments in Emerging Economies
    • Market Trends Towards Multiplexed Testing Platforms for Simultaneous Detection
    • Future Trends: AI and Machine Learning Integration in Diagnostic Processes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Bacterial Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Bacterial Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Bacterial Enteric Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Viral Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Viral Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Viral Enteric Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Parasitic Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Parasitic Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Parasitic Enteric Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Conventional Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Conventional Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Conventional Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Molecular Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Molecular Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Molecular Diagnostic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Testing Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Enteric Disease Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Enteric Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • JAPAN
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • CHINA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • EUROPE
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Enteric Disease Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • GERMANY
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Enteric Disease Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • INDIA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Enteric Disease Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Enteric Disease Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • AFRICA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030

IV. COMPETITION